CIBC Bancorp USA’s Cytosorbents CTSO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-8,632
Closed -$64.6K – 2271
2026
Q2
$64.6K Hold
8,632
– – ﹤0.01% 1885
2026
Q1
$97.8K Buy
+8,632
New +$118K ﹤0.01% 1681

Other funds holding CTSO

CIBC Bancorp USA's CTSO Position: Q3 2026 in Review

CIBC Bancorp USA sold out of Cytosorbents (CTSO) in Q3 2026, closing a stake of 8,632 shares — an estimated $64.6K sold.

CIBC Bancorp USA first reported a position in CTSO in Q1 2026 and held it in 2 quarters. The position peaked at $97.8K in Q1 2026. 28 funds tracked by Wall St. Rank hold CTSO as of Q3 2026.

  • CIBC Bancorp USA reported no remaining Cytosorbents position as of Q3 2026 after selling out during the quarter.
  • CIBC Bancorp USA sold 8,632 Cytosorbents shares in Q3 2026, an estimated $64.6K.
  • CIBC Bancorp USA first reported a position in Cytosorbents in Q1 2026 and held it in 2 quarters.
  • CIBC Bancorp USA's Cytosorbents position peaked at $97.8K in Q1 2026.
  • 28 funds tracked by Wall St. Rank held Cytosorbents as of Q3 2026.

Based on CIBC Bancorp USA's 13F filing for Q3 2026, filed 13 Nov 2026.